Stocks
USANA Health Sciences (USNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 14.3% | 10.9% | 10.8% | 10.1% | 12.3% | 12.1% | ||
| Changes by years, y/y, % | 0pp | -3pp | 0pp | -1pp | +2pp | -4.9% | |||
USANA Health Sciences. EBITDA margin, %
USANA Health Sciences. EBITDA margin, changes, pp
USANA Health Sciences (USNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 8.25% | 11.0% | 11.0% | 12.2% | 14.2% | 12.1% | |
| Changes by years, y/y, % | -1pp | +1pp | +1pp | +1pp | +3pp | |||
| Changes by quarters, q/q, % | 0pp | +3pp | 0pp | +1pp | +2pp | |||
